AstraZeneca Senior Clinical Pharmacometrician to Gothenburg

1 messages 1 people Latest: May 11, 2021
Dear Colleagues, We have another opening for a senior Pharmacometrician in Gothenburg, Sweden. Please see link and text below for more information. Kind regards Dinko Rekic https://careers.astrazeneca.com/job/gothenburg/passionate-senior-clinical-pharmacometrician-to-gothenburg/7684/19270712 Essential in the role: * PhD or equivalent (M.Sc. or Pharm.D.) with at least 3-5 years' experience in quantitative modelling , e.g. knowledge in mathematics and statistics applied to life sciences. * Experience in combined industry and/or Regulatory postdoctorial experience in the field of quantitative modelling. * Strong background in, and an understanding of clinical pharmacology aspects of drug development, preferably in both a small and large molecule setting. * Good knowledge of pharmacokinetics, PKPD and its clinical applications. * Biological understanding of disease and drug action. Desirable in the role: * Track record in creating and delivering on MIDD strategies in clinical drug development programs for both small and large molecules. * Recognized scientific expertise demonstrated by scientific publishing in the field of clinical pharmacology. * Early or late phase clinical development experience. We truly believe that everyone contributes with a unique set of competence. Your curiosity and passion for personal development combined with support from colleagues, mentors and leaders, will ensure you maximise your skills, abilities and contribution. You have a real passion for your subject, along with a collaborative nature and ability to work in multi-disciplinary global teams. ________________________________ Confidentiality Notice: This message is private and may contain confidential and proprietary information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this message is not permitted and may be unlawful.